GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mural Oncology PLC (NAS:MURA) » Definitions » ROA %

Mural Oncology (Mural Oncology) ROA % : -43.76% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Mural Oncology ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Mural Oncology's annualized Net Income for the quarter that ended in Mar. 2024 was $-123.67 Mil. Mural Oncology's average Total Assets over the quarter that ended in Mar. 2024 was $282.62 Mil. Therefore, Mural Oncology's annualized ROA % for the quarter that ended in Mar. 2024 was -43.76%.

The historical rank and industry rank for Mural Oncology's ROA % or its related term are showing as below:

MURA' s ROA % Range Over the Past 10 Years
Min: -551.28   Med: -499.67   Max: -86.58
Current: -86.58

During the past 3 years, Mural Oncology's highest ROA % was -86.58%. The lowest was -551.28%. And the median was -499.67%.

MURA's ROA % is ranked worse than
79.11% of 1546 companies
in the Biotechnology industry
Industry Median: -35.055 vs MURA: -86.58

Mural Oncology ROA % Historical Data

The historical data trend for Mural Oncology's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mural Oncology ROA % Chart

Mural Oncology Annual Data
Trend Dec21 Dec22 Dec23
ROA %
-499.67 -551.28 -123.67

Mural Oncology Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROA % Get a 7-Day Free Trial Premium Member Only -550.72 -69.52 -123.87 -143.48 -43.76

Competitive Comparison of Mural Oncology's ROA %

For the Biotechnology subindustry, Mural Oncology's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mural Oncology's ROA % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mural Oncology's ROA % distribution charts can be found below:

* The bar in red indicates where Mural Oncology's ROA % falls into.



Mural Oncology ROA % Calculation

Mural Oncology's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=-207.447/( (33.75+301.745)/ 2 )
=-207.447/167.7475
=-123.67 %

Mural Oncology's annualized ROA % for the quarter that ended in Mar. 2024 is calculated as:

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=-123.668/( (301.745+263.504)/ 2 )
=-123.668/282.6245
=-43.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2024) net income data. ROA % is displayed in the 30-year financial page.


Mural Oncology  (NAS:MURA) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Mar. 2024 )
=Net Income/Total Assets
=-123.668/282.6245
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-123.668 / 0)*(0 / 282.6245)
=Net Margin %*Asset Turnover
=N/A %*0
=-43.76 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Mural Oncology ROA % Related Terms

Thank you for viewing the detailed overview of Mural Oncology's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mural Oncology (Mural Oncology) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
10 Earlsfort Terrace, Dublin, IRL, D02 T380
Website
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging their core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. The Company operates as one business segment, which is the business of developing medicines designed to address unmet medical needs of patients in the area of oncology.

Mural Oncology (Mural Oncology) Headlines